Journal Mobile Options
Table of Contents
Vol. 52, No. 1, 2004
Issue release date: July 2004
Eur Neurol 2004;52:58–61
(DOI:10.1159/000079546)
Short Reports

New CACNA1A Gene Mutation in a Case of Familial Hemiplegic Migraine with Status epilepticus

Beauvais K.a · Cavé-Riant F.c · De Barace C.b · Tardieu M.d · Tournier-Lasserve E.c · Furby A.a
aExplorations Fonctionnelles Neurologiques, bPédiatrie, Hôpital Y. Le Foll, Saint-Brieuc, cLaboratoire de Cytogénétique, Hôpital Lariboisière, and dNeuropédiatrie, CHU Kremlin Bicêtre, Paris, France

First-Page Preview
Abstract of Short Reports

 goto top of outline Author Contacts

A. Furby, Explorations Fonctionnelles Neurologiques
Hôpital Y. Le Foll, FR–22023 Saint-Brieuc (France)
Tel. +33 2 96 01 71 93, Fax +33 2 96 01 75 03
E-Mail alain.furby@ch-stbrieuc.fr


 goto top of outline Article Information

Published online: July 5, 2004
Number of Print Pages : 4


 goto top of outline Publication Details

European Neurology
Founded 1897 as ‘Monatsschrift für Psychiatrie und Neurologie’

Vol. 52, No. 1, Year 2004 (Cover Date: Released July 2004)

Journal Editor: J. Bogousslavsky, Lausanne
ISSN: 0014–3022 (print), 1421–9913 (Online)

For additional information: http://www.karger.com/journals/ene


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.